In a study assessing the effect of exendin‐4 in addressing mitochondrial and oxidative impairments in neuroblastoma cells, exendin‐4 was found to increase expression of phospho‐Akt/Akt and Bcl‐2, which are cell survival markers. The gene discussed is AKT1; the disease is neuroblastoma.